Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2003 1
2004 1
2005 3
2006 1
2007 1
2008 4
2009 5
2010 2
2011 7
2012 12
2013 11
2014 20
2015 13
2016 12
2017 21
2018 20
2019 19
2020 25
2021 30
2022 17
Text availability
Article attribute
Article type
Publication date

Search Results

201 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Evidence and Recommendations on the Use of Telemedicine for the Management of Arterial Hypertension: An International Expert Position Paper.
Omboni S, McManus RJ, Bosworth HB, Chappell LC, Green BB, Kario K, Logan AG, Magid DJ, Mckinstry B, Margolis KL, Parati G, Wakefield BJ. Omboni S, et al. Hypertension. 2020 Nov;76(5):1368-1383. doi: 10.1161/HYPERTENSIONAHA.120.15873. Epub 2020 Sep 14. Hypertension. 2020. PMID: 32921195 Review.
Telemedicine allows the remote exchange of medical data between patients and healthcare professionals. It is used to increase patients' access to care and provide effective healthcare services at a distance. ...The best proposed healthcare model for telemedicine in hyperte …
Telemedicine allows the remote exchange of medical data between patients and healthcare professionals. It is used to increase patient …
Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2- metastatic breast cancer in US real-world clinical practice.
DeMichele A, Cristofanilli M, Brufsky A, Liu X, Mardekian J, McRoy L, Layman RM, Emir B, Torres MA, Rugo HS, Finn RS. DeMichele A, et al. Breast Cancer Res. 2021 Mar 24;23(1):37. doi: 10.1186/s13058-021-01409-8. Breast Cancer Res. 2021. PMID: 33761995 Free PMC article.
PATIENTS AND METHODS: This was a retrospective observational analysis of electronic health records within the Flatiron Health Analytic Database. ...CONCLUSIONS: In this "real-world" population of patients with HR+/HER2- MBC, palbociclib in combination …
PATIENTS AND METHODS: This was a retrospective observational analysis of electronic health records within the Flatiron …
SynergyFinder 2.0: visual analytics of multi-drug combination synergies.
Ianevski A, Giri AK, Aittokallio T. Ianevski A, et al. Nucleic Acids Res. 2020 Jul 2;48(W1):W488-W493. doi: 10.1093/nar/gkaa216. Nucleic Acids Res. 2020. PMID: 32246720 Free PMC article.
SynergyFinder (https://synergyfinder.fimm.fi) is a stand-alone web-application for interactive analysis and visualization of drug combination screening data. Since its first release in 2017, SynergyFinder has become a widely used web-tool both for the discovery of n …
SynergyFinder (https://synergyfinder.fimm.fi) is a stand-alone web-application for interactive analysis and visualization of drug com …
An open-source drug discovery platform enables ultra-large virtual screens.
Gorgulla C, Boeszoermenyi A, Wang ZF, Fischer PD, Coote PW, Padmanabha Das KM, Malets YS, Radchenko DS, Moroz YS, Scott DA, Fackeldey K, Hoffmann M, Iavniuk I, Wagner G, Arthanari H. Gorgulla C, et al. Nature. 2020 Apr;580(7805):663-668. doi: 10.1038/s41586-020-2117-z. Epub 2020 Mar 9. Nature. 2020. PMID: 32152607 Free PMC article.
On average, an approved drug currently costs US$2-3 billion and takes more than 10 years to develop(1). ...However, despite the fact that large databases of compounds exist, the ability to carry out large-scale structure-based virtual screening on computer clusters in an a …
On average, an approved drug currently costs US$2-3 billion and takes more than 10 years to develop(1). ...However, despite the fact …
Study on Hypoglycemic Effect of the Drug Pair of Astragalus Radix and Dioscoreae Rhizoma in T2DM Rats by Network Pharmacology and Metabonomics.
Guo Q, Niu W, Li X, Guo H, Zhang N, Wang X, Wu L. Guo Q, et al. Molecules. 2019 Nov 8;24(22):4050. doi: 10.3390/molecules24224050. Molecules. 2019. PMID: 31717456 Free PMC article.
Shi Jinmo to improve the treatment of T2DM. However, the exact mechanism involved requires further clarification. ...In conclusion, the result showed that these four targets might be the most relevant targets for the treatment of T2DM with HS. This study clarified t …
Shi Jinmo to improve the treatment of T2DM. However, the exact mechanism involved requires further clarification. ...In conclusion, t …
FDA Approval Summary: Palbociclib for Male Patients with Metastatic Breast Cancer.
Wedam S, Fashoyin-Aje L, Bloomquist E, Tang S, Sridhara R, Goldberg KB, Theoret MR, Amiri-Kordestani L, Pazdur R, Beaver JA. Wedam S, et al. Clin Cancer Res. 2020 Mar 15;26(6):1208-1212. doi: 10.1158/1078-0432.CCR-19-2580. Epub 2019 Oct 24. Clin Cancer Res. 2020. PMID: 31649043
On April 4, 2019, the FDA approved a supplemental new drug application for palbociclib (IBRANCE), to expand the approved indications in women with hormone receptor (HR)-positive, HER2-negative advanced or metastatic breast cancer (MBC) in combination with an …
On April 4, 2019, the FDA approved a supplemental new drug application for palbociclib (IBRANCE), to expand the approved indications …
High-Plex Predictive Marker Discovery for Melanoma Immunotherapy-Treated Patients Using Digital Spatial Profiling.
Toki MI, Merritt CR, Wong PF, Smithy JW, Kluger HM, Syrigos KN, Ong GT, Warren SE, Beechem JM, Rimm DL. Toki MI, et al. Clin Cancer Res. 2019 Sep 15;25(18):5503-5512. doi: 10.1158/1078-0432.CCR-19-0104. Epub 2019 Jun 12. Clin Cancer Res. 2019. PMID: 31189645 Free PMC article.
Here we demonstrate the DSP technology using a 44-plex antibody cocktail to find protein expression that could potentially be used to predict response to immune therapy in melanoma.Experimental Design: The NanoString GeoMx DSP technology is compared with automated Q …
Here we demonstrate the DSP technology using a 44-plex antibody cocktail to find protein expression that could potentially be used to predic …
Automated discovery of drug treatment patterns for endocrine therapy of breast cancer within an electronic medical record.
Savova GK, Olson JE, Murphy SP, Cafourek VL, Couch FJ, Goetz MP, Ingle JN, Suman VJ, Chute CG, Weinshilboum RM. Savova GK, et al. J Am Med Inform Assoc. 2012 Jun;19(e1):e83-9. doi: 10.1136/amiajnl-2011-000295. Epub 2011 Dec 1. J Am Med Inform Assoc. 2012. PMID: 22140207 Free PMC article.
OBJECTIVE: To develop an algorithm for the discovery of drug treatment patterns for endocrine breast cancer therapy within an electronic medical record and to test the hypothesis that information extract …
OBJECTIVE: To develop an algorithm for the discovery of drug treatment patterns for endocrine breast
Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review.
Lee Y, Ragguett RM, Mansur RB, Boutilier JJ, Rosenblat JD, Trevizol A, Brietzke E, Lin K, Pan Z, Subramaniapillai M, Chan TCY, Fus D, Park C, Musial N, Zuckerman H, Chen VC, Ho R, Rong C, McIntyre RS. Lee Y, et al. J Affect Disord. 2018 Dec 1;241:519-532. doi: 10.1016/j.jad.2018.08.073. Epub 2018 Aug 14. J Affect Disord. 2018. PMID: 30153635
A random-effects meta-analysis of proportions and meta-regression analyses were conducted. RESULTS: We identified 639 records: 75 full-text publications were assessed for eligibility; 26 studies (n=17,499) and 20 studies (n=6325) were included in qualitative and quantitati …
A random-effects meta-analysis of proportions and meta-regression analyses were conducted. RESULTS: We identified 639 records: 75 ful …
Treatment Patterns and Outcomes of Patients With Metastatic ER+/HER-2- Breast Cancer: A Multicountry Retrospective Medical Record Review.
Kurosky SK, Mitra D, Zanotti G, Kaye JA. Kurosky SK, et al. Clin Breast Cancer. 2018 Aug;18(4):e529-e538. doi: 10.1016/j.clbc.2017.10.008. Epub 2017 Oct 14. Clin Breast Cancer. 2018. PMID: 29199086
PURPOSE: To describe treatment patterns and clinical outcomes among postmenopausal women with metastatic ER(+)/HER-2(-) breast cancer treated with 2 lines of endocrine therapy or chemotherapy in the metastatic setting. ...RESULTS: Among 9 …
PURPOSE: To describe treatment patterns and clinical outcomes among postmenopausal women with metastatic ER(+)/HER-2(-) bre
201 results